Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alka-Seltzer alcohol warning "unjustified," Bayer says to FDA.

This article was originally published in The Tan Sheet

Executive Summary

ALKA-SELTZER ALCOHOL WARNING "UNJUSTIFIED," BAYER says in Jan. 28 comments on FDA's proposed beverage alcohol warnings for OTC analgesics. Alka-Seltzer, the effervescent gastrointestinal remedy product that contains aspirin, sodium bicarbonate and citric acid, differs from conventional aspirin in "several significant aspects," Bayer states. "As a result of [the] buffering system, and the form of aspirin that is ingested, the aspirin in the Alka-Seltzer solution (sodium salicylate) is present in the stomach almost completely in the ionized form," and, as such, "cannot enter the gastric mucosal cell," and therefore, cannot induce injury, the company maintains. "As Alka-Seltzer does not appear to induce GI damage, it is presumed that it does not have the same direct effect on the gastric mucosa that aspirin does."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088038

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel